Get the Stockscreener App
4.00
3.15%
-0.13
Bionano Genomics Inc stock is traded at $4.00, with a volume of 311.92K.
It is down -3.15% in the last 24 hours and up +13.31% over the past month.
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in the Americas, EMEA, and Asia Pacific, of which the EMEA region generates the majority of its revenue. It generates product revenue from sales of its OGM and Ionic Purification systems and consumables, which include its instruments and their VIA software.
See More
Previous Close:
$4.13
Open:
$4.05
24h Volume:
311.92K
Relative Volume:
3.48
Market Cap:
$13.46M
Revenue:
$36.12M
Net Income/Loss:
$-232.49M
P/E Ratio:
-0.225
EPS:
-17.78
Net Cash Flow:
$-126.87M
1W Performance:
+31.58%
1M Performance:
+13.31%
6M Performance:
-25.37%
1Y Performance:
-87.12%
1-Day Range:
$3.80
$4.08
1-Week Range:
$2.98
$4.234
52-Week Range:
$2.68
$32.79
Bionano Genomics Inc Stock (BNGO) Company Profile
Name
Bionano Genomics Inc
Sector
Industry
Phone
(858) 888-7600
Address
9540 TOWNE CENTRE DRIVE, SAN DIEGO, CA
Compare BNGO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BNGO
Bionano Genomics Inc
|
4.00 | 14.75M | 36.12M | -232.49M | -126.87M | -17.78 |
|
ISRG
Intuitive Surgical Inc
|
476.16 | 172.53B | 9.15B | 2.63B | 1.99B | 7.17 |
|
BDX
Becton Dickinson Co
|
199.66 | 55.89B | 21.39B | 1.61B | 2.55B | 5.56 |
|
ALC
Alcon Inc
|
82.02 | 43.59B | 9.93B | 1.12B | 1.43B | 2.26 |
|
RMD
Resmed Inc
|
293.73 | 41.89B | 5.15B | 1.40B | 1.65B | 9.51 |
|
WST
West Pharmaceutical Services Inc
|
247.85 | 17.48B | 2.96B | 487.70M | 344.00M | 6.68 |
Bionano Genomics Inc Stock (BNGO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-15-24 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| Sep-10-24 | Downgrade | BTIG Research | Buy → Neutral |
| Jan-05-23 | Initiated | Scotiabank | Sector Outperform |
| Dec-12-22 | Resumed | BTIG Research | Buy |
| Jul-18-22 | Resumed | Oppenheimer | Outperform |
| Jun-16-21 | Initiated | BTIG Research | Buy |
| Sep-24-20 | Initiated | Ladenburg Thalmann | Buy |
| Apr-08-20 | Initiated | Oppenheimer | Outperform |
View All
Bionano Genomics Inc Stock (BNGO) Latest News
RSI and MACD Indicate Shift in Bionano Genomics Inc. Sentiment2025 Key Highlights & Capital Protection Trade Alerts - thegnnews.com
Will Bionano Genomics Inc. Benefit From Broader Market BounceWeekly Investment Report & Real-Time Volume Spike Alerts - classian.co.kr
HC Wainwright Raises BNGO Price Target to $11.00 - AInvest
Can Bionano Genomics Inc. Escape Recent Bear Channel2025 Volatility Report & Real-Time Volume Triggers - newsimpact.co.kr
Is It Too Late to Sell Bionano Genomics Inc.Portfolio Gains Report & Fast Exit/Entry Strategy Plans - sundaytimes.kr
Real Time Chart Alerts Flash Bullish on Bionano Genomics Inc.Layoff News & Expert Curated Trade Setups - newsimpact.co.kr
BNGO: HC Wainwright & Co. Raises Price Target to $11.00 | BNGO Stock News - GuruFocus
Bionano Genomics price target raised to $11 from $10 at H.C. Wainwright - TipRanks
Bionano Genomics: HC Wainwright Raises PT to $11 from $10, Maintains Buy - AInvest
Bionano Genomics Q2 2025 Earnings Miss: Erosion of Revenue and EPS Amid Rising Costs - AInvest
Bionano Genomics Q2 Earnings Miss: Volatility Persists Amid Sector-Neutral Trends - AInvest
Can swing trading help recover from Bionano Genomics Inc. lossesTrade Volume Summary & Weekly High Momentum Picks - Newser
Market reaction to Bionano Genomics Inc.’s recent newsDividend Hike & Risk Controlled Daily Trade Plans - Newser
Bionano Genomics (NASDAQ:BNGO) Rating Lowered to Sell at Wall Street Zen - Defense World
Using fundamentals and technicals on Bionano Genomics Inc.July 2025 Opening Moves & Intraday High Probability Alerts - Newser
Price momentum metrics for Bionano Genomics Inc. explainedTrade Performance Summary & Free Real-Time Market Sentiment Alerts - Newser
Signal strength of Bionano Genomics Inc. stock in tech scannersJuly 2025 Institutional & Free Weekly Chart Analysis and Trade Guides - Newser
Why Bionano Genomics Inc. stock attracts strong analyst attentionPortfolio Performance Report & Free Fast Gain Swing Trade Alerts - Newser
Is Bionano Genomics Inc. meeting your algorithmic filter criteriaWeekly Trade Recap & Low Risk Profit Maximizing Plans - Newser
Published on: 2025-08-17 00:12:10 - 선데이타임즈
Bionano Genomics Second Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
Bionano Genomics, Inc. (NASDAQ:BNGO) Q2 2025 Earnings Call Transcript - Insider Monkey
Has Bionano Genomics Inc. formed a bullish divergenceJuly 2025 Intraday Action & Long-Term Safe Investment Plans - Newser
How to manage a losing position in Bionano Genomics Inc.2025 AllTime Highs & Free Daily Entry Point Trade Alerts - Newser
Bionano Genomics stock rises on Q1 revenue beat - MSN
Will Bionano Genomics Inc. stock go up in YEARWeekly Investment Recap & Expert Approved Momentum Trade Ideas - mustnews.co.kr
Bionano Genomics Posts Q2 Margin Gain - AOL.com
Bionano Genomics 2025 Q2 Earnings Losses Narrow Sharply, 57.7% Improvement in Net Loss - AInvest
Bionano raises 2025 OGM installation target to 25 as consumables and software revenue climbs 16% - MSN
Bionano Genomics: Strategic Shifts Pay Off with Rising Margins, Stronger Recurring Revenue, and 2025 Growth Upside - AInvest
Bionano Genomics (BNGO) Q2 2025 Revenue Decline Amid Strategic Shift - GuruFocus
Bionano Genomics' Strategic Turnaround and Margin Expansion: Assessing the Sustainability of Gross Margin Gains and the Long-Term Value of the OGM Ecosystem - AInvest
Bionano Genomics shares fall 5.92% premarket after reporting Q2 2025 earnings. - AInvest
Bionano Genomics Q2 2025: Key Contradictions in Strategy, Revenue Growth, and System Utilization - AInvest
BSNL Deploys 4G Mobile Services in Delhi Under Partner Network Access Arrangement - AInvest
Bionano Genomics, Inc. 2025 Q2ResultsEarnings Call Presentation (NASDAQ:BNGO) - Seeking Alpha
Bionano Genomics Q2 2025 Earnings Call Transcript - MarketBeat
Bionano Genomics: A Turning Point Amid Mixed Q2 Earnings—Is the Path to Profitability Clear? - AInvest
Bionano Genomics Inc (BNGO) Q2 2025 Earnings Call Highlights: Navigating Revenue Challenges ... - Yahoo Finance
Bionano Genomics Inc (BNGO) Q2 2025 Earnings Call Highlights: Navigating Revenue Challenges with Strategic Growth Initiatives - GuruFocus
Bionano Genomics Reports Q2 2025 Financial Results - TipRanks
Bionano Q2: Revenue Down 15% YoY, Gross Margin Above 50% - AInvest
Earnings call transcript: Bionano Genomics Q2 2025 sees revenue drop, stock dips - Investing.com Australia
Earnings call transcript: Bionano Genomics Q2 2025 sees revenue drop, stock dips By Investing.com - Investing.com South Africa
Transcript : Bionano Genomics, Inc., Q2 2025 Earnings Call, Aug 14, 2025 - MarketScreener
Bionano Genomics Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Bionano Genomics Reports Q2 Results: Revenue Down 13.4% YoY, Q3 and FY25 Outlook Reiterated. - AInvest
Bionano Reports Second Quarter 2025 Results and Highlights Recent Business Progress - MarketScreener
Major Earnings Scheduled for Release After Thursday's Close - AInvest
Bionano Genomics Q2 Earnings Preview: Consensus EPS -$2.99, Revenue $6.56M - AInvest
Moving Average Trends for Bionano Genomics Inc. Stock: What They IndicatePortfolio Gains Report & Daily Technical Stock Forecast Reports - Newser
Bionano Genomics Inc Stock (BNGO) Financials Data
Revenue
Net Income
Cash Flow
EPS
6.33%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):